Jabil Bolsters Sustainable Packaging Capabilities with Acquisition of Ecologic Brands™
Jabil Inc. (NYSE: JBL) today announced the acquisition of Ecologic Brands, Inc., a leading provider of sustainable packaging specializing in paper bottle and paper-based packaging solutions. Ecologic’s Manteca, California-based operation will join the Jabil Packaging Solutions division, significantly enhancing Jabil’s sustainable packaging platform and offerings for consumer packaged goods (CPG) customers.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210114005367/en/
Jabil Inc. today announced the acquisition of Ecologic Brands, Inc., a leading provider of sustainable packaging specializing in paper bottle and paper-based packaging solutions. (Photo: Business Wire)
“By fueling Ecologic’s unique paper bottle technology with Jabil’s advanced manufacturing solutions and global scale, we aim to help all consumer brands dramatically reduce plastics in packaging worldwide,” said Jason Paladino, senior vice president of Jabil and CEO of Jabil Packaging Solutions. “We’re thrilled to be adding a talented team plus unique and innovative products that directly support our customer demands and Jabil’s enterprise sustainability goals.”
In Ecologic, Jabil Packaging Solutions gains a commercially mature paper bottle solution enabled by deep material expertise and innovative manufacturing processes. Major CPG brands including L’Oréal and Seventh Generation rely on Ecologic’s eco.bottle® to significantly reduce plastic packaging and advance their sustainability goals.
“Ecologic and L’Oreal broke new ground when we incubated the world’s first shower-safe paper bottle for the Seed Phytonutrients project. We’re taking things a step further by bringing this innovative packaging solution to our market-leading Matrix and Redken Brands,” said Shane Wolf, president worldwide, American Professional Brands, L’Oréal Professional Products Division. “Jabil is synonymous with innovation, engineering, automation and scale, so we can only imagine the solutions that will emerge through its union with Ecologic Brands. The possibilities and accessibility for sustainable packaging options are now limitless.”
“Ecologic has been a great partner over the past decade in helping us reimagine the laundry bottle and we’re thrilled to see the acquisition by Jabil,” said Joey Bergstein, CEO of Seventh Generation. “The world needs solutions at scale that reduce plastic waste and improve circularity. Jabil's global scale and deep engineering expertise will propel Ecologic's sustainable packaging solutions to a global footprint, in every category and format type. It’s truly a win for customers, the planet and the industry.”
“I am so proud that our paper bottle was the world’s first breakthrough technology that helps solve the growing environmental challenges caused by plastic,” said Julie Corbett, founder and CEO of Ecologic Brands. “Our pioneering efforts created and validated market opportunity, and now, Jabil provides the ideal mix of global footprint, manufacturing excellence and a customer-first culture to fully pursue our vision of leadership.”
While the team and operations will join Jabil, the company will continue to utilize the Ecologic name as its sustainable packaging product platform. For more information about Ecologic, visit ecologicbrands.com.
About Jabil:
Jabil (NYSE: JBL) is a manufacturing solutions provider with over 260,000 employees across 100 locations in 30 countries. The world's leading brands rely on Jabil's unmatched breadth and depth of end-market experience, technical and design capabilities, manufacturing know-how, supply chain insights and global product management expertise. Driven by a common purpose, Jabil and its people are committed to making a positive impact on their local community and the environment. Visit www.jabil.com to learn more.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210114005367/en/
Contact information
Media Contact
Erin Vadala
Warner Communications
+1 978-468-3076
erin@warnerpr.com
Europe Media Contact
Kirsten Oosterhof
Jabil
+44 (0)7342 073 248
kirsten_oosterhof@jabil.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
NHOA Energy Achieves Great Place To Work Certification in Italy, the United States and Australia18.12.2025 11:53:00 EET | Press release
NHOA Energy, global provider of utility-scale energy storage systems, announces that it has been certified Great Place To Work® in Italy, the United States, and Australia. The certification is based entirely on direct feedback from NHOA Energy employees, gathered through an independent and structured listening process. Great Place To Work® Certification™ assesses the quality of the employee experience across key dimensions such as credibility, respect, fairness, pride, and camaraderie. The results achieved by NHOA Energy reflect a corporate culture built on trust, inclusion, and the consistent commitment to valuing people within a dynamic and international environment. Employees highlighted particularly high levels of appreciation for the ethical and transparent behavior of leaders, the welcoming and inclusive approach toward new hires, and fair treatment across diversity, equity, and inclusion dimensions. A strong majority also expressed pride in working at NHOA Energy and reported a
Regnology Signs an Agreement to Acquire Moody’s Regulatory Reporting & ALM Solutions18.12.2025 11:00:00 EET | Press release
Regnology, a leading provider in regulatory, risk, tax, and finance reporting, as well as supervisory technology, today announced it has signed an exclusive agreement for the acquisition of Moody’s Regulatory Reporting & ALM Solutions business, inclusive of solutions for Basel III compliance, IFRS9 impairment accounting, large bank asset-liability management (ALM), Solvency II insurance reporting, and prudential and statistical regulatory reporting across more than 50 jurisdictions. By integrating Moody’s regulatory capital and liquidity capabilities with Regnology’s regulatory, risk, and finance offerings, the firm is creating a unified, scalable platform designed to meet the full spectrum of financial regulatory compliance and risk requirements. This combined strength positions Regnology as the partner of choice for financial institutions seeking future-ready solutions. At the core of this strategy is Regnology Risk Hub (RRiskHub), an integrated solution designed to deliver a single
Reply Recognized as a Microsoft Azure Expert Managed Services Provider for the Sixth Consecutive Year18.12.2025 11:00:00 EET | Press release
Reply [EXM, STAR: REY] announced today it has been recognized once again as a Microsoft Azure Expert Managed Services Provider (MSP). The renewal reaffirms Reply’s proven expertise and consistent track record in delivering high-quality cloud solutions and services on the Microsoft Azure platform, powered by the deep technical expertise of its specialized companies – Cluster Reply, Solidsoft Reply and Valorem Reply. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218596617/en/ This recognition reflects the ongoing collaboration between Reply - through its companies Cluster Reply, Solidsoft Reply, and Valorem Reply - and Microsoft, supporting shared efforts to deliver value-driven services to enterprise customers. The Azure Expert MSP program is designed by Microsoft to identify and validate partners with proven capabilities in delivering end-to-end Azure services at scale. To qualify, partners must meet a strict set of requ
Takeda’s Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in a Once-Daily Pill, Catalyzing a New Era of Treatment18.12.2025 10:00:00 EET | Press release
Takeda(TSE:4502/NYSE:TAK)today announced positive topline results for the two pivotal Phase 3randomized, multicenter, double-blind, placebo- and active comparator-controlled studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO). The studies demonstrated superiority of zasocitinib compared to placebo for the co-primary endpoints, static Physician Global Assessment (sPGA) 0/1 and Psoriasis Area and Severity Index (PASI) 75, at week 16, with a significantly greater PASI 75 response rate seen as early as week 4 and continuing to increase through week 24. The studies also met all 44 ranked secondary endpoints, including PASI 90, PASI 100 and sPGA 0 against placebo and apremilast, showing the potential of a convenient once-daily pill to deliver complete skin clearance for patients with PsO. “People living with psoriasis continue to seek safe, effective and fast-acting oral therap
DATROWAY ® Type II Variation Application Validated in the EU as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who are Not Candidates for Immunotherapy18.12.2025 09:30:00 EET | Press release
The European Medicines Agency (EMA) has validated the Type II Variation marketing authorization application for DATROWAY® (datopotamab deruxtecan) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. DATROWAY is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/Nasdaq: AZN). The validation confirms the completion of the application and commences the scientific review process by the EMA’s Committee for Medicinal Products for Human Use. The application is based on data from the TROPION-Breast02 phase 3 trial presented in a late-breaking proffered paper session at the 2025 European Society for Medical Oncology (#ESMO25) Congress. In the trial, DATROWAY demonstrated statistically significant and clinical
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom